Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive metastatic breast cancer.

Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, offering a dual-targeting strategy to enhance the therapeutic efficacy of monoclonal antibodies, which is often limited by ...

Zongertinib shows promising results in HER2-mutant NSCLC, offering high response rates and improved quality of life with minimal toxicity.

Two HER2-specific ADCs, trastuzumab emtansine (T-DM1) and trastuzumab deruxtecan (T-DXd), have been approved for the treatment of metastatic breast cancer and proven effective for some patients who ...

AstraZeneca is currently recruiting participants for a Phase 3 clinical trial titled DESTINY-Biliary Tract Cancer-01, which aims to assess the efficacy and safety of Trastuzumab Deruxtecan (T-DXd ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in gastrointestinal cancer.

June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.

Etsy Cracks Down on 3D-Printed Designs, But Who Decides What's Original? The online marketplace now requires computerized creations from 3D printers, Cricuts, and CNC machines to be original ...

The Fujifilm GFX100RF is a 100-megapixel medium format digital camera with a fixed 28mm equivalent F4 lens. The GFX100RF has a recommended price of $4899. It comes in either black or black and silver, ...